These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29110755)

  • 1. Introduction: APOL1-Associated Kidney Disease.
    Pollak MR
    Semin Nephrol; 2017 Nov; 37(6):489. PubMed ID: 29110755
    [No Abstract]   [Full Text] [Related]  

  • 2. APOL1 Nephropathy: From Genetics to Clinical Applications.
    Friedman DJ; Pollak MR
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.
    Quaggin SE; George AL
    J Am Soc Nephrol; 2011 Nov; 22(11):1955-8. PubMed ID: 21997393
    [No Abstract]   [Full Text] [Related]  

  • 4. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 and kidney disease.
    Pollak MR; Genovese G; Friedman DJ
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Friedman DJ; Pollak MR
    Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
    J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
    Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
    Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
    Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
    Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
    Robinson TW; Freedman BI
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):131-136. PubMed ID: 31023447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 kidney risk alleles: population genetics and disease associations.
    Limou S; Nelson GW; Kopp JB; Winkler CA
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide Frequencies of APOL1 Renal Risk Variants.
    Nadkarni GN; Gignoux CR; Sorokin EP; Daya M; Rahman R; Barnes KC; Wassel CL; Kenny EE
    N Engl J Med; 2018 Dec; 379(26):2571-2572. PubMed ID: 30586505
    [No Abstract]   [Full Text] [Related]  

  • 18. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
    Kopp JB; Heymann J; Winkler CA
    Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1 variants may induce HIV-associated nephropathy during HIV primary infection.
    De Laroche M; Desbuissons G; Rouvier P; Barin F; Deray G; Caumes E; Katlama C; Tubiana R; Isnard Bagnis C
    J Antimicrob Chemother; 2017 May; 72(5):1539-1541. PubMed ID: 28100445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.